https://ojs.bbwpublisher.com/index.php/DH/issue/feedDermatological Health2026-04-03T14:18:08+08:00Open Journal Systems<p style="text-align: justify;"><em>Dermatological Health</em> is a peer-reviewed, open access journal that publishes original research articles and review articles related to the prevention, diagnosis, and treatment of disorders of the skin, hair, and nails. The covered topics include, but are not limited to: clinical, investigative, and population-based studies, healthcare delivery and quality of care research, high quality, cost effective, and innovative treatments, new diagnostic techniques, and other topics related to the prevention, diagnosis, and treatment of disorders of the skin, hair, and nails. Each issue includes continuing medical education articles designed to fill practice and knowledge gaps in the delivery of dermatologic care. </p>https://ojs.bbwpublisher.com/index.php/DH/article/view/14302The Therapeutic Value of Valacyclovir Combined with Thymosin Therapy for Esophageal Cancer Complicated with Postherpetic Neuralgia2026-03-25T08:41:15+08:00Jun Zouteam@bbwpublisher.com<p><em>Objective:</em> To evaluate the therapeutic effect of valacyclovir combined with thymosin therapy on patients with esophageal cancer complicated by postherpetic neuralgia (PHN). <em>Methods:</em> A total of 76 patients with esophageal cancer complicated by PHN who were admitted for treatment from January 2023 to January 2025 were selected and evenly divided into two groups using a random number table. The observation group received valacyclovir combined with thymosin therapy, while the reference group received valacyclovir monotherapy. The overall response rate, pain scores, serological indicators, and T-lymphocyte subsets were compared between the two groups. <em>Results:</em> The overall response rate in the observation group was higher than that in the reference group (<em>P</em> < 0.05). After 10 days of treatment, the pain scores in the observation group were lower than those in the reference group, and the serological indicators and T-lymphocyte subsets were superior to those in the reference group (<em>P</em> < 0.05). <em>Conclusion:</em> Valacyclovir combined with thymosin therapy can improve the clinical efficacy in patients with esophageal cancer complicated by PHN, alleviate pain symptoms, regulate serological indicators, and protect the immune function of patients.</p>2026-03-25T08:40:41+08:00Copyright (c) 2026 Author(s)https://ojs.bbwpublisher.com/index.php/DH/article/view/14401An Exploration of the Etiology, Pathogenesis, and Therapeutic Principles of Herpes Zoster Based on the Theory of “Eliminating the Prolonged Stagnation”2026-04-03T14:18:08+08:00Yuanyuan Dengteam@bbwpublisher.comBiqiu Huangteam@bbwpublisher.comXiaochun Weiteam@bbwpublisher.comYuming Zhangteam@bbwpublisher.comWenjie Zhangteam@bbwpublisher.com<p>This paper explores the etiology, pathogenesis, and acupuncture treatment principles of herpes zoster based on the academic perspective of “eliminating the prolonged stagnation” from <em>Ling Shu: Nine Needles and Twelve Source Points</em>. The core pathogenesis of herpes zoster is “deficiency” and “stasis,” with blood stasis being the primary pathological product. The blood stasis obstructs the meridians, triggering neuralgia. The therapeutic principle focuses on promoting blood circulation to resolve stasis and regulating qi to alleviate pain. Guided by “eliminating the prolonged stagnation,” the acupuncture therapy [e.g., He’s <em>Santong</em> needling method: <em>Weitong</em> (normal needling), <em>Wentong</em> (fire needling), and <em>Qiangtong</em> (bloodletting)] acts directly on the stasis areas through techniques like filiform needling, fire needling, and pricking and cupping, thereby effectively alleviating neuralgia caused by herpes zoster. Clinical case studies are used to illustrate the significant advantages of acupuncture therapy under the guidance of the theory of “removing the prolonged stagnation” in treating neuralgia associated with herpes zoster.</p>2026-04-03T14:18:07+08:00Copyright (c) 2026 Author(s)